UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported):		July 31, 2013

 

STAAR Surgical Company
__________________________________________

 

(Exact name of registrant as specified in its charter)

 

Delaware	0-11634	95-3797439
(State or other jurisdiction	(Commission	(I.R.S. Employer
of incorporation)	File Number)	Identification No.)
1911 Walker Ave, Monrovia, California		91016
(Address of principal executive offices)		(Zip Code)

 

Registrant’s telephone number, including area code:		626-303-7902

 

Not Applicable

 

______________________________________________

 

Former name or former address, if changed since last report

 

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

   

Item 2.02 Results of Operations and Financial Condition.

 

On July 31, 2013, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended June 28, 2013, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

 

Item 7.01 Regulation FD Disclosure.

 

On July 31, 2013, the Company held a conference call to discuss the financial results for the quarter ended June 28, 2013.  The Company provided slides to accompany its presentation on the July 31, 2013 conference call, which are available on the Company’s website at www.staar.com.  A copy of the slide presentation is furnished as Exhibit 99.2 to this report and is incorporated herein by this reference.

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No.		Description
99.1		Press release of the Company dated July 31, 2013
99.2		Slide presentation dated July 31, 2013

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

STAAR Surgical Company
July 31, 2013	By:	/s/ Barry G. Caldwell
		Barry G. Caldwell
		President and Chief Executive Officer